Results 291 to 300 of about 200,281 (336)

Beyond NT-proBNP and troponin: How machine learning redefines light-chain cardiac amyloidosis risk assessment. [PDF]

BMC Med Inform Decis Mak
Wu D, Liu X, Li X, Chen J, Lin X, Fang L, Chen W.   +6 more
europepmc   +1 more source

The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives

Journal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista, Diego Martinelli, Marco Spada, Carlo Dionisi‐Vici   +3 more
wiley   +1 more source

Multimodality Imaging in Monoclonal Gammopathy of Undetermined Significance and ATTR Wild-Type Cardiac Amyloidosis. [PDF]

Life (Basel)
Peix A, Perez A, Figueredo Y, Torres L, Cabrera LO, Monzon G, Roblejo H, Perera A, Brink A, Paez D.   +9 more
europepmc   +1 more source

Aryl Hydrocarbon Receptor in Health and Disease

MedComm, Volume 6, Issue 11, November 2025.
Based on the structure and ligands of AhR, this review introduces the AhR‐related signaling pathways and their roles in health and diseases. Agonists and antagonists of AhR as well as new strategies for treatment using the microbial–AhR axis are summarized. A prospect was made for the future use of AhR as a therapeutic target.
Haonan Li, Yufeng Fan, Jizheng Liu, Shumin Dong, Bin Wen, Yunfei Zhang, Xiaocui Wang, Xuemei Duan, Ying Hu, Ze Yan, Huifeng Shang, Yukai Jing   +11 more
wiley   +1 more source

Nonagenarian patients with ATTR cardiac amyloidosis: should they be treated with tafamidis? [PDF]

Eur Heart J
Jobbé-Duval A, Damy T, Broussier A.
europepmc   +1 more source

Amyloidosis: a unifying diagnosis for nephrotic syndrome and congestive cardiac failure

, 2018
Jaskanwal Deep Singh Sara, Ryan B. Khodadadi, Dylan D Barth, Mary Caroline Burton   +3 more
openalex   +2 more sources

mRNA Vaccines: Current Applications and Future Directions

MedComm, Volume 6, Issue 11, November 2025.
mRNA vaccines represent an innovative platform that leverages messenger RNA technology to direct cells to produce specific antigens, thereby eliciting an immune response. mRNA vaccines offer high programmability and significantly improved stability and immunogenicity through nucleotide modifications and delivery systems such as lipid nanoparticles ...
Jianmei Li, Yixin Liu, Jie Dai, Li Yang, Feng Xiong, Jing Xia, Jing Jin, Yangping Wu, Xingchen Peng   +8 more
wiley   +1 more source

Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients. [PDF]

Orphanet J Rare Dis
Hein S, Aus dem Siepen F, Zierleyn SM, Knoll M, Katus HA, Frey N, Kristen AV.   +6 more
europepmc   +1 more source

A Multidisciplinary Team Approach for Diagnosis and Treatment of Patients with AL Amyloidosis

, 2014
Kathleen T. Finn, Salli Fennessey, Anthony C Shelton, Dina Brauneis, Taylor Teschner, Karen Quillen, J. Mark Sloan, Anne S. Renteria, David C. Seldin, Vaishali Sanchorawala   +9 more
openalex   +1 more source

Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain? [PDF]

Eur Heart J Open
Castiglione V, Gentile F, Vergaro G.
europepmc   +1 more source